Benelux Flavonoids Market Size & Outlook, 2025-2033
Benelux Flavonoids Market Insights
- As highlighted in Deep Market Insights analysis, the Benelux Flavonoids Market, worth USD 23.24 Million in 2024, is forecasted to achieve USD 43.08 Million by 2033.
- The Benelux market is anticipated to grow at a CAGR of 7.13% during the period 2026–2033.
- By 2024, Flavonols represented the largest share of the Compound Type market size.
- Anthocyanins is expected to remain the key growth driver within Compound Type, registering the fastest CAGR during the forecast period.
![Benelux Flavonoids Market Size, Share & Growth Report By [2033]](https://deepmarketinsights.com/uploads/charts/benelux-flavonoids-market-benelux-compound-type-226490.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Benelux accounted for 1.19% of the global Flavonoids Market size in 2024.
- By 2033, United States is expected to remain the top global market in terms of size.
- Within Europe, Germany is forecasted to dominate the regional Flavonoids Market size by 2033.
- Benelux will be the fastest-growing market in Europe, projected to achieve USD 43.2 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 23.24 Million |
| Market Size In 2033 | USD 43.08 Million |
| Largest segment | Flavonols |
| Units | Revenue in USD Million |
| CAGR | 7.13% (2025-2033) |
| Segmnetation Covered | |
| Compound Type |
|
| Source |
|
| End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Benelux Flavonoids Market Compound Type 2025-2033 (USD Million)
| Compound Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Flavonols | XX.x | XX.x | XX.x | 9.83 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Flavanones | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Anthocyanins | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Isoflavones | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Benelux Flavonoids Market Source 2025-2033 (USD Million)
| Source | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citrus Fruits | XX.x | XX.x | XX.x | 11.53 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Berries | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Vegetables | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Botanical Extracts | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Benelux Flavonoids Market End Use 2025-2033 (USD Million)
| End Use | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dietary Supplements | XX.x | XX.x | XX.x | 11.26 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Functional Food | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Beverages | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cosmetics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.